LLY

996.4

-0.46%↓

JNJ

243

-0.23%↓

ABBV

228.13

+0.39%↑

NVS

155.63

-3.52%↓

AZN

192.84

-1.3%↓

LLY

996.4

-0.46%↓

JNJ

243

-0.23%↓

ABBV

228.13

+0.39%↑

NVS

155.63

-3.52%↓

AZN

192.84

-1.3%↓

LLY

996.4

-0.46%↓

JNJ

243

-0.23%↓

ABBV

228.13

+0.39%↑

NVS

155.63

-3.52%↓

AZN

192.84

-1.3%↓

LLY

996.4

-0.46%↓

JNJ

243

-0.23%↓

ABBV

228.13

+0.39%↑

NVS

155.63

-3.52%↓

AZN

192.84

-1.3%↓

LLY

996.4

-0.46%↓

JNJ

243

-0.23%↓

ABBV

228.13

+0.39%↑

NVS

155.63

-3.52%↓

AZN

192.84

-1.3%↓

Search

Jazz Pharmaceuticals PLC

Open

SectorHealthcare

184.15 -1.1

Overview

Share price change

24h

Current

Min

180.44

Max

186.97

Key metrics

By Trading Economics

Income

-1.2B

-904M

Sales

72M

1.2B

P/E

Sector Avg

15.775

66.845

EPS

6.64

Profit margin

-75.426

Employees

2,890

EBITDA

43M

279M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+23.46% upside

Dividends

By Dow Jones

Next Earnings

5 May 2026

Market Stats

By TradingEconomics

Market Cap

1.2B

12B

Previous open

185.25

Previous close

184.15

News Sentiment

By Acuity

50%

50%

146 / 351 Healthcare

Technical Score

By Trading Central

Confidence

Very Strong Bearish Evidence

Jazz Pharmaceuticals PLC Chart

Past performance is not a reliable indicator of future results.

Related News

17 Nov 2025, 12:16 UTC

Major Market Movers

Zymeworks, Jazz Pharmaceuticals Shares Rise Following Positive Phase 3 Results for Cancer Treatment

Peer Comparison

Price change

Jazz Pharmaceuticals PLC Forecast

Price Target

By TipRanks

23.46% upside

12 Months Forecast

Average 229.55 USD  23.46%

High 275 USD

Low 195 USD

Based on 12 Wall Street analysts offering 12 month price targets forJazz Pharmaceuticals PLC - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

12 ratings

12

Buy

0

Hold

0

Sell

Technical Score

By Trading Central

N/A / 111.22Support & Resistance

Short Term

Very Strong Bearish Evidence

Intermediate Term

Strong Bearish Evidence

Long Term

Strong Bearish Evidence

Sentiment

By Acuity

146 / 351 Healthcare

News Sentiment

Neutral

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

help-icon Live chat